Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.4 |
mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.4 |